Skip to main content
Cell Communication and Signaling : CCS logoLink to Cell Communication and Signaling : CCS
. 2024 May 27;22:294. doi: 10.1186/s12964-024-01674-y

Correction: The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum

Jing Guo 1, Liping Li 1, Yue Cai 2, Yongbo Kang 1,
PMCID: PMC11129397  PMID: 38802831

Correction: Cell Commun Signal 22, 268 (2024)

10.1186/s12964-024-01611-z

Following publication of the original article [1], the authors reported an error in the corresponding authorship of the article. Yongbo Kang is the sole corresponding author.

The Author contributions statement also included the incorrect information.

The incorrect statement is:

Jing Guo wrote the main manuscript text with the help of Liping Li, Xinwei Huang and Yongbo Kang. All authors reviewed the manuscript.

The corrected statement should read as follows:

Jing Guo wrote the main manuscript text with the help of Liping Li, Yue Cai and Yongbo Kang. All authors reviewed the manuscript.

The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s12964-024-01611-z.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Guo J, Li L, Cai Y, et al. The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum. Cell Commun Signal. 2024;22:268. doi: 10.1186/s12964-024-01611-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cell Communication and Signaling : CCS are provided here courtesy of BMC

RESOURCES